ALPINE IMMUNE SCIENCES, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
ALPINE IMMUNE SCIENCES, INC. had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $22.40 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2024-03-20
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $22.40M.
- 2022-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $19.60M.
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $16.40M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2023-12-31 | $22.40M 10-K · filed 2024-03-20 |
| 2022-12-31 | $19.60M 10-K · filed 2023-03-23 |
| 2021-12-31 | $16.40M 10-K · filed 2022-03-17 |